EH
TAK icon

Equitable Holdings’s Takeda Pharmaceutical TAK Stock Holding History

Equitable Holdings’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$181K Buy
11,613
+773
+7% +$13.6K ﹤0.01% 1610
2025
Q4 		$169K Sell
10,840
-8,643
-44% -$124K ﹤0.01% 1507
2025
Q3 		$285K Buy
+19,483
New +$289K ﹤0.01% 1287

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Equitable Holdings's TAK Position: Q1 2026 in Review

Equitable Holdings increased its Takeda Pharmaceutical (TAK) stake by 7.1% in Q1 2026, buying an estimated $13.6K and bringing the position to 11,613 shares worth $181K. The position accounts for ﹤0.01% of the portfolio, ranked #1610.

Equitable Holdings first reported a position in TAK in Q3 2025 and has held it in 3 quarters since. The position peaked at $285K in Q3 2025. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • Equitable Holdings held 11,613 shares of Takeda Pharmaceutical worth $181K as of Q1 2026.
  • Equitable Holdings bought 773 Takeda Pharmaceutical shares in Q1 2026, an estimated $13.6K.
  • Takeda Pharmaceutical made up ﹤0.01% of Equitable Holdings's portfolio in Q1 2026, its #1610 holding.
  • Equitable Holdings first reported a position in Takeda Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
  • Equitable Holdings's Takeda Pharmaceutical position peaked at $285K in Q3 2025.
  • 358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Equitable Holdings's 13F filing for Q1 2026, filed 15 May 2026.